Study protocol of the ASD-Net, the German research consortium for the study of Autism Spectrum Disorder across the lifespan: From a better etiological understanding, through valid diagnosis, to more effective health care

BMC Psychiatry

Volumn 17, Issue 1, 2017, Pages

  Kamp Becker, Inge ^a   Poustka, Luise ^b,c,d   Bachmann, Christian ^a   Ehrlich, Stefan ^e,f   Hoffmann, Falk ^g   Kanske, Philipp ^h   Kirsch, Peter ⁱ   Krach, Sören ^j   Paulus, Frieder Michel ^j   Rietschel, Marcella ⁱ   Roepke, Stefan ^k   Roessner, Veit ^e   Schad Hansjosten, Tanja ^b   Singer, Tania ^h   Stroth, Sanna ^a   Witt, Stephanie ⁱ   Wermter, Anne Kathrin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g UNIVERSITY OF OLDENBURG   (Germany)

^h MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

ⁱ CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^j UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

ASD net; Autism spectrum disorder; Diagnosis; Genetic; German research network for mental disorders; Health economics; Oxytocin; Screening; Social competence training; Therapy

Indexed keywords

OXYTOCIN; PLACEBO;

ARTICLE; AUTISM; AUTISM ASSESSMENT; BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL RESEARCH; COHORT ANALYSIS; COST CONTROL; COST OF ILLNESS; DISTRESS SYNDROME; EPIGENETICS; EVIDENCE BASED MEDICINE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GERMANY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; LIFESPAN; MACHINE LEARNING; MOTIVATION; MULTICENTER STUDY (TOPIC); NERVE CELL NETWORK; NEUROBIOLOGY; OUTCOME ASSESSMENT; PATIENT MONITORING; PHENOTYPIC VARIATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL BEHAVIOR; SOCIAL COMPETENCE; SOCIAL DISABILITY; THEORY OF MIND; TRANSLATIONAL RESEARCH; COOPERATION; DISABLED PERSON; FEMALE; MALE; MEDICAL RESEARCH; RESEARCH;

AUTISM SPECTRUM DISORDER; BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DISABLED PERSONS; FEMALE; GERMANY; HUMANS; MALE; RESEARCH;

EID: 85019970689     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-017-1362-7     Document Type: Article

References (113)

1. Bauer M, Banaschewski T, Heinz A, Kamp-Becker I, Meyer-Lindenberg A, Padberg F, Schulze TG, et al. The German research network for mental disorders. Nervenarzt. 2016;87(9):989-1010.
2. Constantino JN, Charman T. Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression. Lancet Neurol. 2016;15(3):279-91.
3. Lai M-C, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
4. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, et al. Prevalence of autism-spectrum conditions: UK school-based population study. Brit J Psychiat. 2009;194(6):500-9.
5. Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, et al. Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP). Lancet. 2006;368(9531):210-5.
6. Brugha TS, McManus S, Bankart J, Scott F, Purdon S, Smith J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2012;68(5):459-65.
7. Howlin P, Moss P, Savage S, Rutter M. Social outcomes in mid- to later adulthood among individuals diagnosed with autism and average nonverbal IQ as children. J Am Acad Child Adolesc Psychiatry. 2013;52(6):572-581.e571.
8. Schmidt L, Kirchner J, Strunz S, Brozus J, Ritter K, Roepke S, et al. Psychosocial functioning and life satisfaction in adults with autism Spectrum disorder without intellectual impairment. J Clin Psychol. 2015;71(12):1259-68.
9. Saulnier CA, Klin A. Brief report: social and communication abilities and disabilities in higher functioning individuals with autism and Asperger syndrome. J Autism Dev Disord. 2007;37(4):788-93.
10. Kenworthy L, Case L, Harms MB, Martin A, Wallace GL. Adaptive behavior ratings correlate with symptomatology and IQ among individuals with high-functioning autism spectrum disorders. J Autism Dev Dis. 2010;40(4):416-23.
11. Hofvander B, Delorme R, Chaste P, Nyden A, Wentz E, Stahlberg O, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry. 2009;9:35.
12. Kamp-Becker I, Schroder J, Muehlan H, Remschmidt H, Becker K, Bachmann CJ. Health-related quality of life in children and adolescents with autism Spectrum disorder. Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie. 2011;39(2):123-31.
13. Kamp-Becker I, Schroder J, Remschmidt H, Bachmann CJ. Health-related quality of life in adolescents and young adults with high functioning autism-spectrum disorder. Psychosoc Med. 2010;7.
14. Howlin P, Moss P. Adults with autism spectrum disorders. Can J Psychiatr Rev Can Psychiatr. 2012;57(5):275-83.
15. Poustka L, Kamp-Becker I. Current practice and future avenues in autism therapy in: Current Topics in Behavioural Neurosciences: Social Behavior from Rodents to Humans: Neural Foundations and Clinical Implications edn. Edited by Woehr M, Krach S. Heidelberg: Springer; 2016.
16. Verheij C, Louwerse A, van der Ende J, Eussen MLJM, Van Gool AR, Verheij F, et al. The stability of comorbid psychiatric disorders: a 7 year follow up of children with pervasive developmental disorder-not otherwise specified. J Autism Develop Disorders. 2015;45(12):3939-48.
17. Hill AP, Zuckerman KE, Hagen AD, Kriz DJ, Duvall SW, van Santen J, et al. Aggressive behavior problems in children with autism spectrum disorders: prevalence and correlates in a large clinical sample. Res Autism Spectr Disorders. 2014;8(9):1121-33.
18. Buck TR, Viskochil J, Farley M, Coon H, McMahon WM, Morgan J, et al. Psychiatric comorbidity and medication use in adults with autism spectrum disorder. J Autism Develop Disorders. 2014;44(12):3063-71.
19. Nylander L, Holmqvist M, Gustafson L, Gillberg C. Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) in adult psychiatry. A 20-year register study. Nordic J Psychiatry. 2013;67(5):344-50.
20. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Psy. 2008;47(8):921-9.
21. Levy SE, Giarelli E, Lee LC, Schieve LA, Kirby RS, Cunniff C, et al. Autism spectrum disorder and co-occurring developmental, psychiatric, and medical conditions among children in multiple populations of the United States. J Develop Behav Pediatr. 2010;31(4):267-75.
22. Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics. 2010;7(3):320-7.
23. Autismus-Spektrum-Störungen im Kindes-, Jugend- und Erwachsenenalter - Teil 1: Diagnostik. Interdisziplinäre S3-Leitlinie der DGKJP und der DGPPN sowie der beteiligten Fachgesellschaften, Berufsverbände und Patientenorganisationen. http://www.awmf.org/leitlinien/detail/ll/028-018.html.
24. Dabrowska A, Pisula E. Parenting stress and coping styles in mothers and fathers of pre-school children with autism and down syndrome. J Intellect Disabil Res. 2010;54(3):266-80.
25. Estes A, Olson E, Sullivan K, Greenson J, Winter J, Dawson G, et al. Parenting-related stress and psychological distress in mothers of toddlers with autism spectrum disorders. Brain and Development. 2013;35(2):133-8.
26. Grzadzinski R, Huerta M, Lord C. DSM-5 and autism spectrum disorders (ASDs): an opportunity for identifying ASD subtypes. Molecular Autism. 2013;4(1):12.
27. Veenstra-VanderWeele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology. 2012;37(1):196-212.
28. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008;9(5):341-55.
29. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med. 2016;22(4):345-61.
30. Tick B, Bolton P, Happe F, Rutter M, Rijsdijk F. Heritability of autism spectrum disorders: a meta-analysis of twin studies. Journal of Child Psychology & Psychiatry & Allied Disciplines. 2016;57(5):585-95.
31. Gokoolparsadh A, Sutton GJ, Charamko A, Green NFO, Pardy CJ, Voineagu I. Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies. Cell Mol Life Sci. 2016;73(23):4517-30.
32. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011;1380:42-77.
33. Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci. 2011;15(9):409-16.
34. Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH. The emerging picture of autism spectrum disorder: genetics and pathology. Annu Rev Pathol. 2015;10:111-44.
35. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry. 2009;66(9):947-56.
36. Cross-Disorder Group of the Psychiatric Genomics C. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar a, Goddard ME et al: genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-94.
37. Lord C, Jones RM. Annual research review: re-thinking the classification of autism spectrum disorders. J Child Psychol Psy. 2012;53(5):490-509.
38. Castelli F, Frith C, Happe F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain. 2002;125(Pt 8):1839-49.
39. Lombardo MV, Chakrabarti B, Bullmore ET, Sadek SA, Pasco G, Wheelwright SJ, et al. Atypical neural self-representation in autism. Brain. 2010;133(Pt 2):611-24.
40. Di Martino A, Ross K, Uddin LQ, Sklar AB, Castellanos FX, Milham MP. Functional brain correlates of social and nonsocial processes in autism spectrum disorders: an activation likelihood estimation meta-analysis. Biol Psychiatry. 2009;65(1):63-74.
41. Pelphrey KA, Shultz S, Hudac CM, Vander Wyk BC. Research review: constraining heterogeneity: the social brain and its development in autism spectrum disorder. J Child Psychol Psychiatry Allied Disciplines. 2011;52(6):631-44.
42. Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY. Reward processing in autism. Autism Res. 2010;3(2):53-67.
43. Kohls G, Peltzer J, Schulte-Ruther M, Kamp-Becker I, Remschmidt H, Herpertz-Dahlmann B, et al. Atypical brain responses to reward cues in autism as revealed by event-related potentials. J Autism Develop Disorders. 2011;41(11):1523-33.
44. Schmitz C, Rezaie P. The neuropathology of autism: where do we stand? Neuropathol Appl Neurobiol. 2008;34(1):4-11.
45. Kohls G, Schulte-Rüther M, Nehrkorn B, Müller K, Fink GR, Kamp-Becker I, Herpertz-Dahlmann B, Schultz RT, Konrad K. Reward system dysfunction in autism spectrum disorders. Soc Cogn Affect Neurosci. 2012. doi: 10.1093/scan/nss1033.
46. Dichter GS, Felder JN, Green SR, Rittenberg AM, Sasson NJ, Bodfish JW. Reward circuitry function in autism spectrum disorders. Soc Cogn Affect Neur. 2012;7(2):160-72.
47. Warren Z, Vehorn A, Dohrmann E, Nicholson A, Sutcliffe JS, Veenstra-Vanderweele J. Accuracy of phenotyping children with autism based on parent report: what specifically do we gain phenotyping "rapidly"?. [Erratum appears in Autism Res. 2012;5(2):151]. Autism Res. 2012;5(1):31-8.
48. Corsello C, Hus V, Pickles A, Risi S, Cook EH Jr, Leventhal BL, et al. Between a ROC and a hard place: decision making and making decisions about using the SCQ. J Child Psychol Psy. 2007;48(9):932-40.
49. Norris M, Lecavalier L. Screening accuracy of level 2 autism spectrum disorder rating scales: a review of selected instruments. Autism. 2010;14(4):263-84.
50. Brugha TS, McManus S, Smith J, Scott FJ, Meltzer H, Purdon S, et al. Validating two survey methods for identifying cases of autism spectrum disorder among adults in the community. Psychol Med. 2012;42(3):647-56.
51. Bishop SL, Seltzer MM. Self-reported autism symptoms in adults with autism spectrum disorders. J Autism Develop Disorders. 2012;42(11):2354-63.
52. Hus V, Bishop S, Gotham K, Huerta M, Lord C. Factors influencing scores on the social responsiveness scale. J Child Psychol Psychiatry Allied Disciplines. 2013;54(2):216-24.
53. Dereu M, Roeyers H, Raymaekers R, Meirsschaut M, Warreyn P. How useful are screening instruments for toddlers to predict outcome at age 4? General development, language skills, and symptom severity in children with a false positive screen for autism spectrum disorder. Eur Child Adolesc Psychiatry. 2012;21(10):541-51.
54. Stephens BE, Bann CM, Watson VE, Sheinkopf SJ, Peralta-Carcelen M, Bodnar A, et al. Screening for autism spectrum disorders in extremely preterm infants. J Develop Behav Pediatr. 2012;33(7):535-41.
55. Moore T, Johnson S, Hennessy E, Marlow N. Screening for autism in extremely preterm infants: problems in interpretation. Dev Med Child Neurol. 2012;54(6):514-20.
56. Poustka L, Rothermel B, Banaschewski T, Kamp-Becker I. Intensive verhaltenstherapeutische Interventionsprogramme bei Autismus-Spektrum-Störungen. Kindh Entw. 2012;21(2):81-9.
57. Reichow B, Steiner AM, Volkmar FR. Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2012(7). doi: 10.1002/14651858.CD14008511.pub14651852.
58. Freitag CM, Jensen K, Elsuni L, Sachse M, Herpertz-Dahlmann B, Schulte-Ruther M, et al. Group-based cognitive behavioural psychotherapy for children and adolescents with ASD: the randomized, multicentre, controlled SOSTA-net trial. J Child Psychol Psychiatry Allied Disciplines. 2016;57(5):596-605.
59. Groppe SE, Gossen A, Rademacher L, Hahn A, Westphal L. Grunder G. Oxytocin Influences Processing of Socially Relevant Cues in the Ventral Tegmental Area of the Human Brain. Biol Psychiatry: Spreckelmeyer KN; 2013.
60. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12(9):524-38.
61. Kirsch P. Oxytocin in the socioemotional brain: implications for psychiatric disorders. Dialogues Clin Neurosci. 2015;17(4):463-76.
62. Yamasue H. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders. Psychiatry Clin Neurosci. 2016;70(2):89-99.
63. Guastella AJ, Hickie IB. Oxytocin treatment, circuitry, and autism: a critical review of the literature placing oxytocin into the autism context. Biol Psychiatry. 2016;79(3):234-42.
64. Bakermans-Kranenburg MJ, van I Jzendoorn MH: Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry 2013, 3:e258.
65. Kumsta R, Hummel E, Chen FS, Heinrichs M. Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience. Front Neurosci. 2013;7:83.
66. Macdonald KS. Sex, receptors, and attachment: a review of individual factors influencing response to oxytocin. Front. 2012;6:194.
67. Bakermans-Kranenburg MJ, Van I Jzendoorn MH. A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans. Psychiatric Genetics. 2013. doi: 10.1097/YPG1090b1013e3283643684.
68. Bachmann C, Gerste B, Hoffmann F. Diagnoses of autism spectrum disorders in Germany: time trends in administrative prevalence and diagnostic stability. Autism. 2016. Epub ahead of print. doi: 10.1177/1362361316673977.
69. Kinnear SH, Link BG, Ballan MS, Fischbach RL. Understanding the experience of stigma for parents of children with autism Spectrum disorder and the role stigma plays in Families' lives. J Autism Develop Disorders. 2016;46(3):942-53.
70. Goin-Kochel RP, Mackintosh VH, Myers BJ. How many doctors does it take to make an autism spectrum diagnosis? Autism. 2006;10(5):439-51.
71. Büscher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014;168(8):721-8.
72. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009;13(3):317-36.
73. Höfer J, Hoffmann F, Bachmann C. Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review. Autism. 2016. Epub ahead of print. doi: 10.1177/1362361316646559.
74. Barrett B, Byford S, Sharac J, Hudry K, Leadbitter K, Temple K, et al. Service and wider societal costs of very young children with autism in the UK. J Autism Develop Disorders. 2012;42(5):797-804.
75. Barrett B, Mosweu I, Jones CR, Charman T, Baird G, Simonoff E, et al. Comparing service use and costs among adolescents with autism spectrum disorders, special needs and typical development. Autism. 2014.
76. Peters-Scheffer N, Didden R, Korzilius H, Matson J. Cost comparison of early intensive behavioral intervention and treatment as usual for children with autism spectrum disorder in The Netherlands. Res Dev Disabil. 2012;33(6):1763-72.
77. Weinmann S, Schwarzbach C, Begemann M, Roll S, Willich SN, Greiner W. Verhatlens- und fertigkeitenbasierte Frühinterventionen bei Kindern mit Autismus. DIMDI: Köln; 2009.
78. Jordan MI, Mitchell TM. Machine learning: trends, perspectives, and prospects. Science. 2015;349(6245):255-60.
79. Ecker C, Bookheimer SY, Murphy DGM. Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan. Lancet Neurol. 2015;14(11):1121-34.
80. Bone D, Bishop SL, Black MP, Goodwin MS, Lord C, Narayanan SS. Use of machine learning to improve autism screening and diagnostic instruments: effectiveness, efficiency, and multi-instrument fusion. J Child Psychol Psychiatry Allied Disciplines. 2016;57(8):927-37.
81. Wall DP, Dally R, Luyster R, Jung J-Y, Deluca TF. Use of artificial intelligence to shorten the behavioral diagnosis of autism. PLoS ONE. 2012;7(8):e43855.
82. Wall DP, Kosmicki J, Deluca TF, Harstad E, Fusaro VA. Use of machine learning to shorten observation-based screening and diagnosis of autism. Transl Psychiatry. 2012;2:e100.
83. Bölte S, Poustka F, Constantino JN. Assessing autistic traits: cross-cultural validation of the social responsiveness scale (SRS). Autism Res. 2008;1(6):354-63.
84. Woerner W, Becker A, Rothenberge A. Normative data and scale properties of the German parent SDQ. Eur J Child Adolesc Psychiatry. 2004;13(2):11-6.
85. Poustka L, Rehm A, Holtmann M, Bock M, Böhmert C, Dziobek I. Dissociation of cognitive and affective empathy in adolescents with autisms Spectrum disorders: introducing the Multiphased empathy test for adolescents (MET-J). Kindh Entw. 2010;19(9):177-83.
86. Stiensmeier-Pelster J, Braune-Krickau M, Schuermann M, Duda K. Children's depression inventory - German version. Goettingen: Hogrefe. 2014;
87. Lohaus A, Eschenbeck H, Kohlmann C-W, Klein-Hessling J. Questionnaire for the measurement of stress and coping in children and adolescents (SSKJ). Göttingen: Hogrefe; 2006.
88. Starfield B, Riley AW, Green BF, Ensminger ME, Ryan SA, Kelleher K, et al. The adolescent child health and illness profile. A population-based measure of health. Med Care. 1995;33(5):533-66.
89. Adolphs R. The social brain: neural basis of social knowledge. Annu Rev Psychol. 2009;60:693-716.
90. Castelli F, Happe F, Frith U, Frith C. Movement and mind: a functional imaging study of perception and interpretation of complex intentional movement patterns. NeuroImage. 2000;12(3):314-25.
91. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. NeuroImage. 2002;17(1):317-23.
92. Spreckelmeyer KN, Krach S, Kohls G, Rademacher L, Irmak A, Konrad K, et al. Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. Soc. 2009;4(2):158-65.
93. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage. 2007;38(1):95-113.
94. Preckel K, Kanske P, Singer T, Paulus F, Krach S. Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: a randomized, placebo-controlled, double-blind and crossover trial. BMC Psychiatry. 2016;16. doi: 10.1186/s12888-12016-11036-x.
95. Rademacher L, Krach S, Kohls G, Irmak A, Grunder G, Spreckelmeyer KN. Dissociation of neural networks for anticipation and consumption of monetary and social rewards. NeuroImage. 2010;49(4):3276-85.
96. Spreckelmeyer KN, Krach S, Kohls G, Rademacher L, Irmak A, Konrad K, et al. Anticipation of monetary and social reward differently activates mesolimbic brain structures in men and women. Soc Cogn Affect Neurosci. 2009;4(2):158-65.
97. Kanske P, Bockler A, Trautwein F-M, Parianen Lesemann FH, Singer T. Are strong empathizers better mentalizers? Evidence for independence and interaction between the routes of social cognition. Soc. 2016;11(9):1383-92.
98. Kanske P, Bockler A, Trautwein F-M, Singer T. Dissecting the social brain: introducing the EmpaToM to reveal distinct neural networks and brain-behavior relations for empathy and theory of mind. NeuroImage. 2015;122:6-19.
99. Bone D, Goodwin MS, Black MP, Lee C-C, Audhkhasi K, Narayanan S. Applying machine learning to facilitate autism diagnostics: pitfalls and promises. Journal of Autism & Developmental Disorders. 2015;45(5):1121-36.
100. Hofmann SG, Fang A, Brager DN. Effect of intranasal oxytocin administration on psychiatric symptoms: a meta-analysis of placebo-controlled studies. Psychiatry Res. 2015;228(3):708-14.
101. Yamasue H, Yee JR, Hurlemann R, Rilling JK, Chen FS, Meyer-Lindenberg A, et al. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci. 2012;32(41):14109-17.
102. Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010;67(7):692-4.
103. Lee SY, Lee AR, Hwangbo R, Han J, Hong M, Bahn GH. Is oxytocin application for autism Spectrum disorder evidence-based? Exp. 2015;24(4):312-24.
104. Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A. 2010;107(9):4389-94.
105. Auyeung B, Lombardo MV, Heinrichs M, Chakrabarti B, Sule A, Deakin JB, et al. Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism. Transl Psychiatry. 2015;5:e507.
106. Althaus M, Groen Y, Wijers AA, Noltes H, Tucha O, Hoekstra PJ. Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder. Neuropsychologia. 2015;79(Pt A):53-69.
107. Cochran DM, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry. 2013;21(5):219-47.
108. Baribeau DA, Anagnostou E. Oxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuits. Front. 2015;9:335.
109. Yatawara CJ, Einfeld SL, Hickie IB, Davenport TA, Guastella AJ. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry. 2016;21(9):1225-31.
110. Guastella AJ, Gray KM, Rinehart NJ, Alvares GA, Tonge BJ, Hickie IB, et al. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. J Child Psychol Psychiat Allied Discipl. 2015;56(4):444-52.
111. Munesue T, Nakamura H, Kikuchi M, Miura Y, Takeuchi N, Anme T, et al. Oxytocin for male subjects with autism Spectrum disorder and comorbid intellectual disabilities: a randomized pilot study. Front Psychiat Front Res Foundation. 2016;7:2.
112. Dadds MR, MacDonald E, Cauchi A, Williams K, Levy F, Brennan J. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord. 2014;44(3):521-31.
113. Anagnostou E, Soorya L, Brian J, Dupuis A, Mankad D, Smile S, et al. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Res. 2014;1580:188-98.